Ropivacaine and Fentanyl for Labor Epidural Initiation
Recruiting
Phase 3
Interventional Study
Pregnancy
Labor and Delivery
Labor Analgesia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 50 (estimated)
- Sponsor
- University of California, San Francisco · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is being done to determine the most effective dose of medicine to use to initially provide effective pain relief within the first 30 minutes of receiving an epidural for pain labor during labor. The study team will also study any side effects related to the epidural medication and patients' satisfaction with the quality of pain relief after receiving the epidural.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with singleton vertex pregnancies in active labor (latent or spontaneous labor or after induction of labor)
* Cervical dilatation between 2 and 7 cm
* Requesting neuraxial labor analgesia
* Age 18 or older
Exclusion Criteria:
* Significant obstetric disease (e.g., p…
Contacts